Molecular Endocrinology · 2007 · 479 citations · 63 references
Life SciencesMolecular BiologyOncologyCell SignalingGene ExpressionMolecular OncologyMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerRna InterferenceTranslation RegulationUntranslated Regions3' Untranslated Region RegulationEstrogen Receptor ExpressionEstrogen ReceptorsMicrorna In CancerMicrorna Regulation In CancerMicrorna-mediated Translational RepressionTranscriptional RepressionTranslational Repression By Micrornas
Micro-RNAs are small noncoding RNAs, which diminish the stability and/or translation of mRNAs. This study examined whether miR-206, previously shown to be elevated in estrogen receptor (ER)alpha-negative breast cancer, regulates the expression of ERalpha. Two putative miR-206 sites, (hERalpha1 and hERalpha2), were found in silico within the 3'-untranslated region of human ERalpha mRNA. Transfection of MCF-7 cells with pre-miR-206 or 2'-O-methyl antagomiR-206 specifically decreased or increased, respectively, ERalpha mRNA levels. Overexpression of pre-miR-206 reduced ERalpha and beta-actin protein levels, with no effect on ERbeta, E-cadherin, or glyceraldehyde-3-phosphate dehydrogenase. Reporter constructs containing the hERalpha1 or hERalpha2 binding sites inserted into the 3'-untranslated region of the luciferase mRNA conferred a 1.6- and 2.2-fold repression of luciferase activity, respectively, in HeLa cells. Both miR-206 sites responded accordingly to exogenous hsa-pre-miR-206 and 2'-O-methyl antagomiR-206, and both sites were rendered inactive by mutations that disrupted hybridization to the 5'-seed of miR-206. A C-->T single nucleotide polymorphism in the hERalpha1 site increased repression of luciferase activity to approximately 3.3-fold in HeLa cells. MiR-206 levels were higher in ERalpha-negative MB-MDA-231 cells than ERalpha-positive MCF-7 cells, but only the ERalpha1 site mediated significantly more repression in reporter constructs. MiR-206 expression was strongly inhibited by ERalpha agonists, but not by an ERbeta agonist or progesterone, indicating a mutually inhibitory feedback loop. These findings provide the first evidence for the posttranscriptional regulation of ERalpha by a micro-RNA in the context of breast cancer.
63
The Human Genome Browser at UCSC
W. James Kent, Charles W. Sugnet, Terrence S. Furey et al. · Genome Research · 2002 · 10.9K citations · Full text
The International HapMap Project
Richard A. Gibbs, John W. Belmont, Paul Hardenbol et al. · Nature · 2003 · 6.2K citations · Full text
Prediction of Mammalian MicroRNA Targets
Benjamin P. Lewis, I‐hung Shih, Matthew W. Jones-Rhoades et al. · Cell · 2003 · 5.2K citations · Full text
The nuclear RNase III Drosha initiates microRNA processing
Yoontae Lee, Chiyoung Ahn, Jinju Han et al. · Nature · 2003 · 5.1K citations